RPS27P26

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, RPS27P26 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RPS27P26 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RPS27P26 RNA is associated with better overall survival. In most high-consensus cancer types, elevated RPS27P26 expression acts as an unfavorable survival marker, although some lineages such as STAD and UCEC show a favorable association.

STAD, LUSC, and UVM are the cancer types where RPS27P26 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
STADOSTertileIV0.8380.261.02045view →
LUSCDFSTertileAll0.1910.403.00245view →
UVMDFSTertileAll0.3180.756.01036view →
SKCMDFSTertileIV0.0350.476.00236view →
BLCAOSTertileIV0.0510.600<.00127view →
GBMOSTertileAll0.2610.435.00618view →
OVDFSTertileIV0.2990.493.01318view →
PCPGOSTertileAll0.0780.954.00918view →
UCECDFSTertileII,III,IV0.9030.484.03412view →
THYMDFSTertileIII,IV0.2050.774.0079view →
PRADOSTertileAll0.9520.996.0376view →
Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RPS27P26–STAD (OS)

Kaplan–Meier survival curve for RPS27P26 RNA-high vs -low samples in STAD.

Open the STAD breakdown →

Exploration